Ribavirin - Therapeutic Goods Administration (TGA)
... Participants were treated for 48 weeks and followed for efficacy and safety for 24 weeks post treatment. Patients could discontinue ribavirin while remaining on PEG-IFN alfa-2a. However, if PEG-IFN alfa-2a was discontinued, the patient had to be discontinued from the study. Systemic antiviral treatm ...
... Participants were treated for 48 weeks and followed for efficacy and safety for 24 weeks post treatment. Patients could discontinue ribavirin while remaining on PEG-IFN alfa-2a. However, if PEG-IFN alfa-2a was discontinued, the patient had to be discontinued from the study. Systemic antiviral treatm ...
Medium-chain Triglyceride Ketogenic Diet, An Effective Treatment
... menu is provided. Foods do not need to be weighed; intake is based on portion size which is based on diabetic exchanges. Vitamins and minerals are supplemented to meet individual needs.[15,16] The balance of low glycemic CHO in combination with fat results in steady glucose levels.[15,16] The MAD do ...
... menu is provided. Foods do not need to be weighed; intake is based on portion size which is based on diabetic exchanges. Vitamins and minerals are supplemented to meet individual needs.[15,16] The balance of low glycemic CHO in combination with fat results in steady glucose levels.[15,16] The MAD do ...
Development and Implementation of a Comprehensive Heart Failure
... support from the HFSA or any other source for the development of the guideline. Support was provided by the HFSA administrative staff, but the writing of the document was performed on a volunteer basis primarily by the Committee. Information concerning financial relationships that might represent co ...
... support from the HFSA or any other source for the development of the guideline. Support was provided by the HFSA administrative staff, but the writing of the document was performed on a volunteer basis primarily by the Committee. Information concerning financial relationships that might represent co ...
Antigout Drugs
... Effects on the skin. Skin reactions are the most common adverse effects of allopurinol. One report calculated that of 215 adverse effects noted over a 16year period 188 (87.4%) were related to the skin or mucous membranes.1 An analysis by the Boston Collaborative Drug Surveillance Program of data on ...
... Effects on the skin. Skin reactions are the most common adverse effects of allopurinol. One report calculated that of 215 adverse effects noted over a 16year period 188 (87.4%) were related to the skin or mucous membranes.1 An analysis by the Boston Collaborative Drug Surveillance Program of data on ...
UCL MD Thesis - UCL Discovery
... The International Continence Society (ICS) defines Overactive Bladder (OAB) as “Urgency, with or without urge incontinence, usually with frequency and nocturia” with the synonyms the overactive bladder syndrome, urge syndrome or urgency-frequency syndrome. These terms may be used provided that there ...
... The International Continence Society (ICS) defines Overactive Bladder (OAB) as “Urgency, with or without urge incontinence, usually with frequency and nocturia” with the synonyms the overactive bladder syndrome, urge syndrome or urgency-frequency syndrome. These terms may be used provided that there ...
Nicotrol® Inhaler
... that if they continue to smoke while using the product, they may experience adverse effects due to peak nicotine levels higher than those experienced from smoking alone. If there is a clinically significant increase in cardiovascular or other effects attributable to nicotine, the treatment should be ...
... that if they continue to smoke while using the product, they may experience adverse effects due to peak nicotine levels higher than those experienced from smoking alone. If there is a clinically significant increase in cardiovascular or other effects attributable to nicotine, the treatment should be ...
Comparative Effectiveness of Eye Drops vs. Laser Trabeculoplasty
... field loss. Glaucoma is classified into two broad categories: open-angle glaucoma (OAG) and angleclosure glaucoma; more than 80% of cases are OAG.1 Glaucoma can progress without causing symptoms until the disease is quite advanced, leading to visual impairment and blindness. The second leading cause ...
... field loss. Glaucoma is classified into two broad categories: open-angle glaucoma (OAG) and angleclosure glaucoma; more than 80% of cases are OAG.1 Glaucoma can progress without causing symptoms until the disease is quite advanced, leading to visual impairment and blindness. The second leading cause ...
Antimigraine Drugs
... not obtain complete pain relief.1,3,4,9 Intranasal dihydroergotamine1,4 and inhaled ergotamine have also been used to treat acute attacks; injectable dihydroergotamine has usually been reserved for emergency settings.4 Since individual attacks are difficult to treat it is probably more effective to ...
... not obtain complete pain relief.1,3,4,9 Intranasal dihydroergotamine1,4 and inhaled ergotamine have also been used to treat acute attacks; injectable dihydroergotamine has usually been reserved for emergency settings.4 Since individual attacks are difficult to treat it is probably more effective to ...
CIRSE Quality Assurance Guidelines for Superior Vena Cava
... effective in relieving SVCO at initial presentation [30]. Reported re-obstruction rates following successful relief of obstructive symptoms range from 0-40%, however patency is restored in most patients with re-intervention. The only independent risk factor for endovascular therapeutic failure in a ...
... effective in relieving SVCO at initial presentation [30]. Reported re-obstruction rates following successful relief of obstructive symptoms range from 0-40%, however patency is restored in most patients with re-intervention. The only independent risk factor for endovascular therapeutic failure in a ...
Treatment of Hyperhidrosis
... addition, another botulinum toxin A product, Dysport, has been evaluated in RCTs for treatment of axillary hyperhidrosis(14) and palmar hyperhidrosis.(9) Moreover, a small RCT published in 2007 compared Botox and Dysport and found similar levels of efficacy and safety with the 2 products.(11) One of ...
... addition, another botulinum toxin A product, Dysport, has been evaluated in RCTs for treatment of axillary hyperhidrosis(14) and palmar hyperhidrosis.(9) Moreover, a small RCT published in 2007 compared Botox and Dysport and found similar levels of efficacy and safety with the 2 products.(11) One of ...
S Safe and Effective Treatment of Seborrheic Dermatitis T
... and foam, and hydrocortisone cream, ointment, or lotion are popular therapies for seborrheic dermatitis, sometimes in combination with antibiotics.1 Steroids, which target inflammation, may be useful ancillary therapies if topical antifungal agents have not eradicated the disease. However, high-pote ...
... and foam, and hydrocortisone cream, ointment, or lotion are popular therapies for seborrheic dermatitis, sometimes in combination with antibiotics.1 Steroids, which target inflammation, may be useful ancillary therapies if topical antifungal agents have not eradicated the disease. However, high-pote ...
ZALDIAR® film-coated tablets (Tramadol 37.5 mg/Paracetamol 325
... as a result of the nature and severity of the illness, then careful, regular monitoring should take place (with breaks in the treatment, where possible), to assess whether continuation of the treatment is necessary. ...
... as a result of the nature and severity of the illness, then careful, regular monitoring should take place (with breaks in the treatment, where possible), to assess whether continuation of the treatment is necessary. ...
PSORIASIS AND ANESTHETIC CONSIDERATIONS A B , A
... psoriasis among patients and siblings3. The lifetime risk for developing psoriasis is 4% for an individual if the parents of the individual do not have psoriasis. However, the risk increases to 28% if one of the parents is afflicted and to 65% if both parents have psoriasis. It is believed that geno ...
... psoriasis among patients and siblings3. The lifetime risk for developing psoriasis is 4% for an individual if the parents of the individual do not have psoriasis. However, the risk increases to 28% if one of the parents is afflicted and to 65% if both parents have psoriasis. It is believed that geno ...
Kingston Hospital June 2013 GUIDELINES FOR THE MANAGEMENT OF
... drugs given differ; the doses quoted below are for adults. (For children or small individuals the adrenaline should be given at 1 microgram/kg.) Management The success of treatment is highly dependent on early identification of anaphylaxis as a cause of dyspnoea or hypotension and rapid use of adren ...
... drugs given differ; the doses quoted below are for adults. (For children or small individuals the adrenaline should be given at 1 microgram/kg.) Management The success of treatment is highly dependent on early identification of anaphylaxis as a cause of dyspnoea or hypotension and rapid use of adren ...
Cerebral Palsy: An Overview
... The presentation of cerebral palsy can be global mental and physical dysfunction or isolated disturbances in gait, cognition, growth, or sensation. It is the most common childhood physical disability and affects 2 to 2.5 children per 1,000 born in the United States. The differential diagnosis of cer ...
... The presentation of cerebral palsy can be global mental and physical dysfunction or isolated disturbances in gait, cognition, growth, or sensation. It is the most common childhood physical disability and affects 2 to 2.5 children per 1,000 born in the United States. The differential diagnosis of cer ...
August 2011 - Physical Therapy Journal
... global connections for the physical therapy community and our potential impact on promoting world health became crystal clear at the 16th International World Confederation for Physical Therapy Congress (WCPT) in Amsterdam, the Netherlands, in June. At last count, about 5,300 clinicians traveled from ...
... global connections for the physical therapy community and our potential impact on promoting world health became crystal clear at the 16th International World Confederation for Physical Therapy Congress (WCPT) in Amsterdam, the Netherlands, in June. At last count, about 5,300 clinicians traveled from ...
Lidocaine -An Old Drug for New Indication
... Chandigarh, Punjab, India; E-mail: [email protected] ...
... Chandigarh, Punjab, India; E-mail: [email protected] ...
PRACTICE GUIDELINE FOR THE Treatment of Patients With
... Eli Lilly and Company, Forest Pharmaceuticals, Inc., and Wyeth Pharmaceuticals. Dr. Blacker reports no competing interests. Dr. Rovner has served on speakers bureaus for Pfizer and Forest Pharmaceuticals, Inc. Dr. Rummans has received a research grant from the Linse Bock Foundation. Dr. Schneider has ...
... Eli Lilly and Company, Forest Pharmaceuticals, Inc., and Wyeth Pharmaceuticals. Dr. Blacker reports no competing interests. Dr. Rovner has served on speakers bureaus for Pfizer and Forest Pharmaceuticals, Inc. Dr. Rummans has received a research grant from the Linse Bock Foundation. Dr. Schneider has ...
PHS
... effective medications than were identified in the previous Guideline. Seven different effective first-line smoking cessation medications are now approved by the FDA for treating tobacco use and dependence. In addition, multiple combinations of medications have been shown to be effective. Thus, the c ...
... effective medications than were identified in the previous Guideline. Seven different effective first-line smoking cessation medications are now approved by the FDA for treating tobacco use and dependence. In addition, multiple combinations of medications have been shown to be effective. Thus, the c ...
MSA - What You Need to Know pdf - The Multiple System Atrophy
... System Atrophy poses a considerable diagnostic challenge to doctors and medical researchers. Though much remains to be learned, ongoing research efforts and advancements in biotechnology continually bring science closer to understanding the causes of MSA. As an informed patient, your knowledge can h ...
... System Atrophy poses a considerable diagnostic challenge to doctors and medical researchers. Though much remains to be learned, ongoing research efforts and advancements in biotechnology continually bring science closer to understanding the causes of MSA. As an informed patient, your knowledge can h ...
60 - Glucocorticoid Therapy
... Apart from the steroid configuration, biologic characteristics of glucocorticoids also depend on whether they are in free form (as alcohol) or are chemically bound (as ester or salt). In their free form, glucocorticoids are virtually insoluble in water, so they can be used in tablets but not in pare ...
... Apart from the steroid configuration, biologic characteristics of glucocorticoids also depend on whether they are in free form (as alcohol) or are chemically bound (as ester or salt). In their free form, glucocorticoids are virtually insoluble in water, so they can be used in tablets but not in pare ...
Management of multiple sclerosis
Several therapies for multiple sclerosis (MS) exist, although there is no known cure. Multiple sclerosis is a chronic inflammatory demyelinating disease that affects the central nervous system (CNS).The most common initial course of the disease is the relapsing-remitting subtype, which is characterized by unpredictable attacks (relapses) followed by periods of relative remission with no new signs of disease activity. After some years, many of the people who have this subtype begin to experience neurologic decline without acute relapses. When this happens it is called secondary progressive multiple sclerosis. Other, less common, courses of the disease are the primary progressive (decline from the beginning without attacks) and the progressive-relapsing (steady neurologic decline and superimposed attacks). Different therapies are used for patients experiencing acute attacks, for patients who have the relapsing-remitting subtype, for patients who have the progressive subtypes, for patients without a diagnosis of MS who have a demyelinating event, and for managing the various consequences of MS.The primary aims of therapy are returning function after an attack, preventing new attacks, and preventing disability. As with any medical treatment, medications used in the management of MS may have several adverse effects, and many possible therapies are still under investigation. At the same time different alternative treatments are pursued by many patients, despite the paucity of supporting, comparable, replicated scientific study.This article focuses on therapies for standard MS; borderline forms of MS have particular treatments that are excluded.